CClinicalTrials.gg
CompletedNCT03843216Updated Feb 18, 2019

End Growth Results for Conservative Treatment for Idiopahitc Scoliosis

An observational study in Scoliosis; Adolescence and Scoliosis Idiopathic, sponsored by Istituto Scientifico Italiano Colonna Vertebrale. Completed at 1 site in Italy. Open to participants aged 10 Years to 18 Years. Per ClinicalTrials.gov, last updated 2019-02-18.

Sponsored by Istituto Scientifico Italiano Colonna Vertebrale · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
1,938
Ages
10 Years to 18 Years
Sex
All
01

Study summary

This study evaluates in a prospectively collected multicenter cohort the existence, characteristics and determinants of EBPCA, the obtained results and their determinant, the rate of over- and under-treatment and their determinants.

Read the detailed description

Since an evidence-based personalised conservative approach (EBPCA) to Adolescent Idiopathic Scoliosis has never been checked, the investigators studied a prospectively collected multicenter cohort with the aim to verify in the different clinical situations 1) the existence, characteristics and determinants of EBPCA; 2) the obtained results and their determinant; 3) the rate of over- and under-treatment and their determinants. These results are expected to check the actual evidence in everyday clinic, to provide a benchmark for future studies, and to inform guidelines producers and consequently health policy in high income countries, but also and particularly in low-middle income countries where surgery is difficult due to the high costs, and missing competences and structures.

02

Conditions studied

  • Scoliosis; Adolescence
  • Scoliosis Idiopathic

Browse trials for

03

In context

Scoliosis

594 studies on the registry are indexed under Scoliosis; 139 are open to participants now.

This study's enrollment of 1,938 is above the median of 89 across 233 observational studies indexed under Scoliosis.

Browse Scoliosis studies →

Lead sponsor

Istituto Scientifico Italiano Colonna Vertebrale is the lead sponsor of 12 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Scoliotic patients that were referred to a tertiary clinic specialized on spine deformity.

Inclusion criteria

  • diagnosis of Adolescent Idiopathic Scoliosis (AIS),
  • curves between 11 and 45° at start,
  • Risser test between 0 and 2.
  • Since our Institute receive many participants for a second opinion, we considered only participants in charge, defined as those who came at least three times to our facilities

Exclusion criteria

Exclusion Criteria:

  • previous bracing;
  • absence of x-rays in the 3 months before/after the start and the end of treatment/observation.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
1,938 participants (actual)
Patient registry
No

Interventions

  • Otherobservation

    patients not treated

  • OtherPhysiotherapic scoliosis specific exercise

    Specific exercise according to the SEAS (Scientific Exercises Approach to Scoliosis) protocol

  • Devicebrace

    different kind of braces being elastic, rigid or very rigid. All devices are custom made. The hours of application per day varied from 18 to 24h.

06

What researchers measure

Primary outcomes

  1. Number of patients achieving specific results

    Outcomes were calculated as number of patients achieving specific results at the end of growth, including: 1) remaining below the significant prognostic thresholds of 30° and 50°; 2) improved or progressed beyond the measurement error of 5°; 3) achieving the treatment aims proposed by the current Guidelines : primary (optimal) and secondary (minimal); 4) receiving under- or over-treatment, that have been defined during study planning in relationship to the ideal final result.

    Time frame: End of growth as defined as radiological evidence of Risser 5 or Risser 4 and two years of no growth in height.

07

Study locations

1 site
  • ISICO
    Milan, Mi 20141, Italy
08

References and documents

Publications

  • Negrini S, Donzelli S, Aulisa AG, Czaprowski D, Schreiber S, de Mauroy JC, Diers H, Grivas TB, Knott P, Kotwicki T, Lebel A, Marti C, Maruyama T, O'Brien J, Price N, Parent E, Rigo M, Romano M, Stikeleather L, Wynne J, Zaina F. 2016 SOSORT guidelines: orthopaedic and rehabilitation treatment of idiopathic scoliosis during growth. Scoliosis Spinal Disord. 2018 Jan 10;13:3. doi: 10.1186/s13013-017-0145-8. eCollection 2018. PubMed 29435499 ↗
  • Weinstein SL, Dolan LA, Wright JG, Dobbs MB. Effects of bracing in adolescents with idiopathic scoliosis. N Engl J Med. 2013 Oct 17;369(16):1512-21. doi: 10.1056/NEJMoa1307337. Epub 2013 Sep 19. PubMed 24047455 ↗
  • Di Felice F, Zaina F, Donzelli S, Negrini S. The Natural History of Idiopathic Scoliosis During Growth: A Meta-Analysis. Am J Phys Med Rehabil. 2018 May;97(5):346-356. doi: 10.1097/PHM.0000000000000861. PubMed 29493563 ↗
  • Negrini S, Hresko TM, O'Brien JP, Price N; SOSORT Boards; SRS Non-Operative Committee. Recommendations for research studies on treatment of idiopathic scoliosis: Consensus 2014 between SOSORT and SRS non-operative management committee. Scoliosis. 2015 Mar 7;10:8. doi: 10.1186/s13013-014-0025-4. eCollection 2015. PubMed 25780381 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 18, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03843216
Lead sponsor
Istituto Scientifico Italiano Colonna Vertebrale
Responsible party
Sponsor
First posted
Feb 18, 2019
Start date
Jan 2016
Primary completion
Jan 2018
Completion
Jul 2018
Last update
Feb 18, 2019

Study contacts

Stefano Negrini, MD, Prof
principal investigator · stefano.negrini@isico.it

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion